Clinical factors for predicting malignancy in patients with PSA < 10 ng/mL and PI‐RADS 3 lesions
- 10 August 2020
- journal article
- research article
- Published by Wiley in Asia-Pacific Journal of Clinical Oncology
- Vol. 17 (2) , E94-E99
Abstract
Aim: To determine clinical risk factors in patients with PI‐RADS 3 lesions and prostate‐specific antigen (PSA) < 10 ng/mL.Methods: In this prospective study, all patients underwent multiparametric magnetic resonance imaging. Following the 2‐5 core fusion‐targeted biopsy, standard 12‐core prostate biopsy was performed in each patient (combined biopsy). The cutoff values were calculated with receiver‐operating characteristic analysis. First, univariate logistic regression analysis was used to evaluate the relationship between total eight parameters and prostate cancer. Subsequently, multiple logistic regression analysis was performed to the parameters associated with prostate cancer.Results: Two hundred and eighty‐eight patients were included in the study. Some clinical parameters are determined to be significant in univariate and multiple logistic regression analyses, including PSA, free/total PSA ratio, PSA density (PSA/total prostate volume), positive family history of PCa, and PI‐RADS 3 lesion diameter. Patients were classified between 0 and 5 according to the number of risk factors. While the risk of cancer was 7.1% in patients with one or less risk factors, the PCA rate was 45.2% among patients with all risk factors.Conclusion: In patients with PI‐RADS 3 lesion and PSA < 10 ng/mL, histopathological results of biopsy can be estimated with higher accuracy using some clinical parameters.Keywords
Funding Information
- Erciyes University Scientific Research Projects Coordination (TSG-2016-5200)
This publication has 27 references indexed in Scilit:
- Multiparametric Magnetic Resonance Imaging (MRI) and MRI–Transrectal Ultrasound Fusion Biopsy for Index Tumor Detection: Correlation with Radical Prostatectomy SpecimenEuropean Urology, 2016
- Predictive value of negative 3T multiparametric magnetic resonance imaging of the prostate on 12‐core biopsy resultsBJU International, 2016
- PI-RADS Prostate Imaging – Reporting and Data System: 2015, Version 2European Urology, 2016
- Neutrophil-to-lymphocyte ratio predicts prostatic carcinoma in men undergoing needle biopsyOncotarget, 2015
- Likert score 3 prostate lesions: Association between whole‐lesion ADC metrics and pathologic findings at MRI/ultrasound fusion targeted biopsyJournal of Magnetic Resonance Imaging, 2015
- mp-MRI Prostate Characterised PIRADS 3 Lesions are Associated with a Low Risk of Clinically Significant Prostate Cancer - A Retrospective Review of 92 Biopsied PIRADS 3 LesionsCurrent Urology, 2015
- Prostate Imaging Reporting and Data System and Likert Scoring System: Multiparametric MR Imaging Validation Study to Screen Patients for Initial BiopsyRadiology, 2015
- Identification of Threshold Prostate Specific Antigen Levels to Optimize the Detection of Clinically Significant Prostate Cancer by Magnetic Resonance Imaging/Ultrasound Fusion Guided BiopsyJournal of Urology, 2014
- Prostate-specific antigen and prostate-specific antigen density cutoff points among Indonesian population suspected for prostate cancerProstate International, 2013
- Use of the Percentage of Free Prostate-Specific Antigen to Enhance Differentiation of Prostate Cancer From Benign Prostatic DiseaseJAMA, 1998